Skip to main content
. 2017 Jan 1;63(1):E1–E8.

Table I.

Characteristics of patients

Number (%) PEP
All patients 1334 115 (8.6%)
Mean age ± SD (years) 65.5 ± 12.7
Sex Male 857 (64.2%) 72 (8.4%)
Female 477 (35.8%) 43 (9.0%)

Previous PEP Presence 81(6.1%) 36 (44.4%)
Absence 1253(93.9%) 79 (6.3%)

Previous acute pancreatitis Presence 52(3.9%) 17 (52.7%)
Absence 1282(96.1%) 98 (7.6%)

Suspected SOD Presence 24 (1.8%) 8 (33.3%)
Absence 1310 (98.2%) 107 (8.2%)

Cannulation time < 15 min 992 (74.4%) 70 (7.1%)
≥ 15 min 342 (25.6%) 45 (13.2%)

Total procedure time < 30 min 464 (34.8%) 28 (6.0%)
≥ 30 min 870 (65.2%) 87 (10.0%)

EST Performed 175 (13.1%) 20 (11.4%)
Not performed 1159 (86.9%) 95 (8.2%)

Precut sphincterotomy Performed 18 (1.4%) 0 (0%)
Not performed 1316 (98.6%) 115 (8.7%)

Pancreatic duct injection Performed 923 (69.2%) 92 (10.0%)
Not performed 411 (30.8%) 23 (5.6%)

Pancreatic duct IDUS Performed 75 (5.6%) 9 (12%)
Not performed 1259 (94.4%) 106 (8.4%)

Bile duct IDUS Performed 120 (9.0%) 13 (10.8%)
Not performed 1214 (91.0%) 102 (8.4%)

Pancreatic duct aspiration cytology Performed 147 (11.0%) 14 (9.5%)
Not performed 1187 (89.0%) 101 (8.5%)

Bile duct aspiration cytology Performed 79 (5.9%) 10 (12.7%)
Not performed 1255 (94.1%) 105 (8.4%)

Pancreatic duct brush cytology Performed 108 (8.1%) 18 (16.7%)
Not performed 1226 (91.9%) 97 (7.9%)

Bile duct brush cytology Performed 146 (10.9%) 16 (11.0%)
Not performed 1188 (89.1%) 99 (9.1%)

Endoscopic pancreatic stenting Performed 131(9.8%) 9 (6.9%)
Not Performed 1203 (90.2%) 106 (8.8%)

EPS: Endoscopic pancreatic stenting; ERCP: endoscopic retrograde cholangiopancreatography; EST: endoscopic sphincterotomy; IDUS: intraductal ultrasonography; SOD: sphincter of Oddi dysfunction.